Prediction of (Covid-19) Patients Outcomes by Lung Ultrasound Score

Document Type : Original papers

Authors

Critical care department, Faculty of medicine, Beni Suef University, Egypt

Abstract

Background: Lung ultrasound (LUS) imaging is a quick, non-invasive, accurate and quantitative method. Its prognostic value in those with Coronavirus disease 2019 (COVID-19) is still unknown. Aim: To know if poor outcomes in COVID-19 patients could be predicted on the basis of LUS score at admission. Patients and methods: A prospective cohort study involved 40 patients diagnosed with COVID-19 according to Egyptian protocol for management of COVID-19 patients. All patients subjected to full history taking, clinical assessment, laboratory investigation (routine labs, serum ferritin, C-reactive  protein, LDH and D-dimer) and imaging (chest X-ray, ultrasound and CT without contrast). Results: The baseline LUS score of patients was significantly higher among patients who needed mechanical ventilation and patients who died at admission (p=0.012 and 0.015 at admission, respectively) and at 4th day (0.026 and 0.024 at 4th day, respectively). Baseline LUS score could predict the need of MV at cutoff value >17 with sensitivity 73.68%, specificity 66.67%, PPV 66.7% and NPV 73.7% and could predict the mortality at cut off value 17 with sensitivity 70%, specificity 65%, PPV 66.7%, NPV 68.4%. Conclusion: Lung ultrasound score was a strong predictor of mortality, ICU admission, and the need for mechanical ventilation in patients with critical condition.

Keywords


  1. Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalized patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of EurRespir J. 2020;55 (6):2000562. https://doi.org/10.1183/13993003.00562-2020.
  2. Yang X, Yu Y, Xu J, et Clinical course and outcomes of critically ill patientswith SARS- CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8 (5):475–81.
  3. Chen N, Zhou M, Dong X, et Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptive study. Lancet. 2020;395 (10223):507–13.
  4. Wu C, Chen X, Cai Y, Associated RF, with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease Pneumonia in Wuhan, China. JAMA. Intern 2019; https://doi.org/10.1001/jamainternmed.2020.0994.
  5. Huang G, Kovalic AJ, Graber CJ. Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity.Emerg Infect 2020. https://doi.org/10.3201/eid2608.201160.
  6. Luo X, Zhou W, Yan X, et al. Prognostic value of C-reactive protein in patients with COVID-19. Clin Infect 2020. https://doi.org/10.1093/cid/ciaa641.
  7. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395 (10241):1907–18.
  8. Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30434-5.
  9. Ferré A, Guillot M, Lichtenstein D, et Lung ultrasound allows thediagnosis of weaning- induced pulmonary oedema. Intensive Care Med.2019;45 (5):601–8.
  10. Wang G, Ji X, Xu Y, Xiang X. Lung ultrasound: a promising tool to monitorventilator- associated pneumonia in critically ill Critical Care. 2016;20(1):320.
  11. Barskova T, Gargani L, Guiducci S, et al. Lung ultrasound for the screeningof interstitial lung disease in very early systemic Ann Rheum Dis.2013;72 (3):390–5.
  12. Denina M, Scolfaro C, Silvestro E, et al. Lung Ultrasound in Children withCOVID-19. 2020. https://doi.org/10.1542/peds.2020-1157.13. Youssef A, Serra C, Pilu G. Lung ultrasound in the COVID-19 pandemic: apractical guide for obstetricians and gynecologists. Am J Obstetric Gynecol.2020;223 (1):128–31.
  13. Wang B, Zhang L, Zhang D, et al. Bedside ultrasound in assessment of 510severe and critical patients with COVID-19 pneumonia in Wuhan, China.Adv Ultras Diagn Therapy. 2020;4 (2):60–6.
  14. Platz E, Merz AA, Jhund PS, Vazir A, Campbell R, McMurray JJ. Dynamicchanges and prognostic value of pulmonary congestion by lungultrasound in acute and chronic heart failure: a systematic Eur JHeart Fail. 2017;19 (9):1154–63.
  15. Gargani L, Bruni C, Romei C, et Prognostic value of lung ultrasoundB-lines in systemic sclerosis. Chest.2020. https://doi.org/10.1016/j.chest2020.03.075.
  16. Management Protocol for COVID-19 Patients Version 1.4/30th May 2020 Ministry of health and population (MOHP), Egypt.. Ministry of Health and Population.
  17. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is Published March 13, 2020.Accessed January 28, 2020: 20.
  18. An JY, Unsdorfer KML, Weinreb BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung- RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: Reporting and Data Systems. RadioGraphics. 2019;39(5):1435–1436.
  19. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, et al. International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung Intensive Care Med. 2012 Apr;38(4):577-91. doi: 10.1007/s00134-012-2513-4. Epub 2012 Mar 6.
  20. Mojoli F, Bouhemad B, Mongodi S, Lichtenstein D. Lung ultrasound forcritically ill Am J RespirCrit Care Med. 2019;199 (6):701–14.
  21. de Alencar JC, Marchini JF, Marino LO, da Costa Ribeiro SC, Bueno CG, da Cunha VP, Neto FL, Neto RA, Souza HP. Lung ultrasound score predicts outcomes in COVID-19 patients admitted to the emergency Annals of intensive care. 2021 Dec;11(1):1-8.
  22. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV Front Med.2020; 14(2):185192. doi:10.1007/s11684-020-0754-0
  23. Ji L, Cao C, Gao Y, Zhang W, Xie Y, Duan Y, Kong S, You M, Ma R, Jiang L, Liu J. Prognostic value of bedside lung ultrasound score in patients with COVID-19. Critical 2020 Dec;24(1):1-2.
  24. Nouvenne A, Zani MD, Milanese G, Parise A, Baciarello M, Bignami EG, et al.. Lung ultrasound in COVID-19 pneumonia: correlations with chest CT on hospital admission. 2020;99(7):617-24.
  25. Barssoum K, Victor V, Salem A, Kumar A, Mubasher M, Hassib M, et Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID‐ 19: A systematic review. Echocardiography. 2021 Aug;38(8):1365-404.
  26. Gullett J, Donnelly JP, Sinert R, Hosek B, Fuller D, Hill H, et al. Interobserver agreement in the evaluation of B-lines using bedside J Crit Care. 2015 Dec;30((6)):1395– 9.
  27. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Med. 2020;26:681-7.